Viz HCM vs Viz CTP

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Viz HCM

by Viz.ai

Viz CTP

by Viz.ai

AI Verdict

Viz HCM is a specialized tool for detecting Hypertrophic Cardiomyopathy (HCM) through real-time ECG analysis and coordinating cardiac care. In contrast, Viz CTP is a broader platform that utilizes over 50 FDA-cleared algorithms primarily for analyzing medical imaging to detect various diseases and streamline clinical workflows. While both are from Viz.ai and focus on AI-powered disease detection and care coordination, their core input data (ECG vs. medical imaging) and specific disease focus make them adjacent rather than direct competitors.

Choose Viz HCM if…

Choose Viz HCM if your primary objective is to rapidly identify suspected Hypertrophic Cardiomyopathy (HCM) patients through real-time ECG analysis and streamline their subsequent cardiac care. This tool is specifically designed to leverage AI for early HCM detection, significantly reducing diagnosis time and coordinating multidisciplinary care teams.

View Viz HCM →

Choose Viz CTP if…

Choose Viz CTP if your organization requires a comprehensive AI-powered platform for broad disease detection and intelligent care coordination across numerous conditions, primarily leveraging medical imaging analysis. This solution offers over 50 FDA-cleared algorithms to analyze various imaging modalities, providing real-time mobile access to high-fidelity imaging and automating critical measurements for faster diagnosis and treatment.

View Viz CTP →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Viz HCM	Viz CTP
Pricing	Subscription-based	Subscription model
Deployment	Cloud-based platform, integrated into hospital IT systems (EHR, PACS).	Cloud-native solution, integrates with PACS and EHRs.
BAA Available	Yes AI-estimated	Unknown
FDA Status	Yes AI-estimated	1 AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Viz CTP

Viz CTP explicitly highlights 'Real-time, mobile access to high-fidelity imaging (DICOM viewer, 3D manipulation),' which suggests a more advanced and versatile imaging review capability on mobile devices. While both tools emphasize integration and mobile alerts, Viz CTP's detailed imaging features likely offer enhanced usability for workflows centered around medical images.

Clinical Value

Viz CTP

Viz CTP boasts '50+ FDA-cleared algorithms' for analyzing medical imaging and streamlining workflows across numerous conditions. In contrast, Viz HCM is specialized for Hypertrophic Cardiomyopathy detection. The broader application and extensive suite of algorithms in Viz CTP offer a wider range of clinical utility and potential impact across a healthcare system.

Pricing & Value

Viz HCM

Viz HCM provides a clear value proposition by explicitly stating that CMS reimbursement is available for specific CPT codes (0764T and 0765T) with a national payment rate. This transparency regarding potential cost recovery offers a more tangible financial benefit and clearer path to value compared to Viz CTP's general subscription model based on algorithms and population size.

Enterprise Readiness

Tie

Both Viz HCM and Viz CTP are cloud-based solutions from Viz.ai, claiming seamless integration with EHR and PACS systems, HIPAA compliance, BAA, and FDA clearance. Based on the provided structured facts, there are no distinguishing features that would make one tool more enterprise-ready than the other.

Innovation

Viz CTP

While Viz HCM demonstrates innovation in applying AI to ECG analysis for HCM, Viz CTP showcases a broader and deeper level of innovation with '50+ FDA-cleared algorithms' and advanced imaging features such as 'AI-powered motion artifact correction for CTP' and 3D manipulation. This extensive portfolio of algorithms and sophisticated imaging capabilities suggests a more comprehensive and impactful innovative platform.

Support & Docs

Tie

Both products are from Viz.ai, and the company offers a comprehensive support infrastructure including 24/7 urgent support, in-app assistance, a knowledge base, and a dedicated customer success team. Viz.ai also provides extensive documentation through its Trust Center, covering security, privacy, and clinical validation. As these are company-wide resources, there's no specific information to differentiate support or documentation quality between the two individual tools.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Viz HCM	Viz CTP
Tool Name	Viz HCM	Viz CTP
Primary Detection Focus	AI-powered ECG analysis for Hypertrophic Cardiomyopathy (HCM) detection	AI-powered disease detection leveraging over 50 FDA-cleared algorithms to analyze medical imaging (e.g., CT perfusion maps, LVO detection, ICH volume, subdural thickness/midline shift)
Real-time Analysis/Detection	Real-time disease detection from electrocardiograms	Real-time, mobile access to high-fidelity imaging (DICOM viewer, 3D manipulation); Automated image analysis and interpretation
Care Coordination/Communication	Mobile-based alerts and notifications to multidisciplinary care teams; Automated direction of patients to appropriate care specialists; Streamlines cardiac care coordination	Intelligent care coordination and communication platform (HIPAA-compliant messaging)
Integration with Clinical Systems	Seamless integration with existing clinical workflows, EHR, and PACS systems	EHR integration; Integrates with PACS and EHRs

Videos

Demos, reviews, and walkthroughs featuring Viz HCM and Viz CTP.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What specific medical conditions are addressed by Viz HCM versus Viz CTP?

Viz HCM is an AI tool specifically designed for the real-time detection of suspected Hypertrophic Cardiomyopathy (HCM) using ECG analysis. Viz CTP offers broader AI-powered disease detection with over 50 FDA-cleared algorithms, primarily analyzing medical imaging for conditions such as stroke and other neurovascular conditions.

What types of clinical data do these tools primarily analyze?

Viz HCM primarily analyzes real-time 12-lead ECG data to detect patterns consistent with hypertrophic cardiomyopathy. In contrast, Viz CTP leverages AI to analyze various medical imaging, specifically computed tomography (CT) perfusion scans of the brain, to generate perfusion maps and other parameters for conditions like stroke.

Are there specific reimbursement opportunities associated with using either tool?

Yes, Viz HCM has CMS reimbursement available for CPT codes 0764T and 0765T, with a national payment rate of $128.90 effective January 1, 2025, for AI-enabled ECG analysis to detect cardiac pathology. The provided information for Viz CTP does not specify particular CPT codes for reimbursement, though Viz.ai has received New Technology Add-on Payment (NTAP) renewal for its stroke triage module, Viz LVO.

How do these tools integrate into existing hospital IT systems and clinical workflows?

Both Viz HCM and Viz CTP are cloud-based platforms designed for seamless integration with existing hospital IT systems, including EHR and PACS. They aim to streamline clinical workflows and care coordination.

What are the key differences in the care coordination and communication features?

Viz HCM provides mobile-based alerts and notifications to multidisciplinary care teams and automates the direction of patients to appropriate specialists for HCM. Viz CTP offers an intelligent care coordination and communication platform with HIPAA-compliant messaging and real-time, mobile access to high-fidelity imaging, including 3D manipulation.

What are the primary benefits each tool offers in terms of diagnosis and treatment?

Viz HCM significantly reduces diagnosis time and streamlines cardiac care coordination for Hypertrophic Cardiomyopathy, aiming for earlier detection and improved access to specialized care. Viz CTP enhances the speed and accuracy of stroke diagnosis and treatment planning through automated image analysis, interpretation (e.g., CT perfusion maps, LVO detection), and prioritized worklists, leading to improved patient outcomes.